When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Last reviewed: 16 Mar 2025
Last updated: 06 Mar 2025

Summary

Definition

History and exam

Key diagnostic factors

  • childhood and adolescence
  • worsening pain over weeks to months
  • mass/swelling
  • male sex

Other diagnostic factors

  • race/ethnicity
  • tall stature
  • high birthweight
  • limp
  • history of trauma
  • limited range of motion

Risk factors

  • childhood and adolescence
  • Paget disease
  • radiation therapy
  • Rothmund-Thomson syndrome
  • familial retinoblastoma syndrome
  • Li-Fraumeni syndrome
  • race/ethnicity
  • nonfamilial deleterious germline variants
  • male sex
  • tall stature
  • high birthweight
  • chemotherapy exposure

Diagnostic tests

1st tests to order

  • conventional radiographs
  • bone biopsy
  • magnetic resonance imaging (MRI)
  • computed tomography (CT)
  • CT thorax
  • bone scan
  • whole body fluorodeoxyglucose (FDG)-PET/CT
  • complete blood count
  • serum alkaline phosphatase
  • serum lactate dehydrogenase

Treatment algorithm

Contributors

Authors

David Loeb, MD, PhD

Chief

Division of Pediatric Hematology, Oncology, and Marrow & Blood Cell Transplantation

Children's Hospital at Montefiore

Associate Professor, Pediatrics

Associate Professor, Developmental and Molecular Biology

Albert Einstein College of Medicine

Bronx

NY

Disclosures

DL declares that he has no competing interests.

Acknowledgements

Dr David Loeb would like to gratefully acknowledge Dr Luminita Rezeanu and Dr Michael J. Klein, the previous contributors to this topic.

Disclosures

LR and MJK declare that they have no competing interests.

Peer reviewers

Edward Sauter, MD, PhD

Professor of Surgery

Ellis Fischel Cancer Center

University of Missouri

Columbia

MO

Disclosures

ES declares that he has no competing interests.

Rachael Windsor, BSc, MBBS, MSc, MRCPCH

Locum Consultant Paediatric Oncologist

University College Hospital

London

UK

Disclosures

RW declares that she has no competing interests.

Use of this content is subject to our disclaimer